Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis.

Saved in:
Bibliographic Details
Title: Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis.
Authors: Bhattacharya, Dipankar1 (AUTHOR), Becker, Christine2,3 (AUTHOR), Readhead, Benjamin2,4 (AUTHOR), Goossens, Nicolas1,5 (AUTHOR), Novik, Jacqueline2 (AUTHOR), Fiel, Maria Isabel6 (AUTHOR), Cousens, Leslie P.7 (AUTHOR), Magnusson, Björn8 (AUTHOR), Backmark, Anna8 (AUTHOR), Hicks, Ryan9 (AUTHOR), Dudley, Joel T.2 (AUTHOR), Friedman, Scott L.1 (AUTHOR) Scott.Friedman@mssm.edu
Source: Scientific Reports. 10/21/2021, Vol. 11 Issue 1, p1-17. 17p.
Database: Academic Search Ultimate
Description
ISSN:20452322
DOI:10.1038/s41598-021-99008-2